OX40L-expressing recombinant modified vaccinia virus Ankara induces potent antitumor immunity via reprogramming Tregs
Ning Yang(Shenyang Pharmaceutical University), Liang Deng(Memorial Sloan Kettering Cancer Center), Shuaitong Liu(Memorial Sloan Kettering Cancer Center), Yi Wang(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Charles M. Rice(Rockefeller University), Shanza Baseer Tariq(Memorial Sloan Kettering Cancer Center), Anthony Rossi(Memorial Sloan Kettering Cancer Center), Jenny Xiang(Cornell University), Gregory Mazo(Memorial Sloan Kettering Cancer Center), Jedd D. Wolchok(Cornell University), Adrian Y. Tan(NewYork–Presbyterian Hospital), Joseph M. Luna(Rockefeller University), Tuo Zhang(Cornell University), Wei Yan(Q Therapeutics (United States)), Taha Merghoub(Cornell University), John Choi(Q Therapeutics (United States)), Jiahu Wang
Cited by 24
Related Papers
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Nivolumab plus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2013|4.2k
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k